Dr. Saro Khemichian is a board certified transplant hepatologist who received his medical degree from University of Southern California Keck School of medicine. He then went on to complete his residency in Internal Medicine followed by Gastroenterology fellowship at LAC+USC Medical Center in Los Angeles. Dr. Khemichian then completed an extra year of training for Transplant Hepatology at Keck Medical Center of USC.
Dr. Khemichian's clinical interests include gastroenterology, hepatitis B, hepatitis C, chronic liver disease and liver transplantation. His research interests include complications of chronic liver disease, liver transplant, and treatment of hepatitis C infection.
Department of Medicine, USC: Intern of the Year Award, 2004
Georgetown University: Physiology Student of the Year, 1999
Randomized trial of 1-week versus 2-week intervals for endoscopic ligation in the treatment of patients with esophageal variceal bleeding. Hepatology. 2016 Aug; 64(2):549-55. View in: PubMed
Comparison of Demographic and Clinical Characteristics of Hispanic and Asian Chronic Hepatitis B Patients in Southern California. J Clin Gastroenterol. 2016 Aug; 50(7):602-7. View in: PubMed
Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation. Dig Dis Sci. 2015 Sep; 60(9):2807-12. View in: PubMed
Sofosbuvir and Simeprevir Therapy for Recurrent Hepatitis C Infection After Liver Transplantation. Transplant Direct. 2015 Jul; 1(6):e21. View in: PubMed
Combined liver-kidney transplantation is preferable to liver transplant alone for cirrhotic patients with renal failure. Transplantation. 2012 Aug 27; 94(4):411-6. View in: PubMed
Hepatic dysfunction in hyperthyroidism. Gastroenterol Hepatol (N Y). 2011 May; 7(5):337-9. View in: PubMed
Pulmonary vein leiomyosarcoma. Intern Med J. 2006 Dec; 36(12):793-4. View in: PubMed